Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil)

NCT06306300 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30000

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Specialist - Epclusa 400Mg-100Mg Tablet
DRUG: Non- specialist - Epclusa 400Mg-100Mg Tablet

Sponsor

Oswaldo Cruz Foundation

Collaborators

[object Object]